Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.86 (
clotting enzyme
)
176
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have reported the cloning from mouse genomic DNA of a fragment encoding a G-protein-coupled receptor related to the receptor for the blood
clotting enzyme
thrombin. Like the thrombin receptor this receptor is activated by proteolytic cleavage of its extracellular amino terminus. Because the physiological agonist at the receptor was unknown, we provisionally named it
proteinase-activated receptor 2
(
PAR-2
). Here we present a
PAR-2
cDNA of 2729 nucleotides that differs from the published genomic sequence at the 5' end, including a part of the protein coding region. The differences do not affect the peptide sequence of the activating proteinase cleavage site proper, but may include amino acid residues important for enzyme-substrate recognition. Analysis of the
PAR-2
gene structure showed that the cDNA 5' end is derived from a separate exon located about 10 kilobases away from the 3' exon. Results from a primer extension experiment indicate that transcription starts at a unique site around nucleotide -203 respective to the translation initiation ATG. Chinese hamster ovary cells transfected with either the
PAR-2
cDNA or a construct made from the published
PAR-2
genomic sequence responded with intracellular calcium mobilization to stimulation with 1 nM trypsin, 10 microM
PAR-2
-activating peptide (SLIGRL), or 1 microM thrombin receptor-activating peptide (SFLLRN). Untransfected cells responded only to stimulation with thrombin receptor activating peptide. Only transcripts corresponding to the
PAR-2
cDNA could be detected in three mouse tissues examined.
...
PMID:The mouse proteinase-activated receptor-2 cDNA and gene. Molecular cloning and functional expression. 789 Jul 26